Members

Principal Investigator

Dr. Anshu Agrawal

aagrawal@uci.edu

Dr. Agrawal received her PhD from Lucknow University, the premier University in India in immunomodulation using liposomes in infectious diseases such as leishmaniasis and tuberculosis. She subsequently worked at the United Nations’ International Center for Genetic Engineering and Biotechnology, New Delhi in the Immunology group, where she successfully delineated several immune mechanisms responsible for the phenomenon of immunodominance of B cell epitopes.

Dr. Agrawal is a recipient of the Indo-French international award and fellowship to work at Institute Curie at Paris, where she focused on the role of Fc receptors and cancer. She was recruited as a senior postdoctoral fellow in the laboratory of Dr. Bali Pulendran at Emory Vaccine Center, Atlanta, where she carried out one of the most outstanding research in the pathogenesis of anthrax, which was published in the scientific journal, Nature. Dr. Agrawal has also focused on the modulating T cell responses via dendritic cells which led to several seminal publications in JI. She has published papers in journals of high scientific repute such as the Immunity and Journal of Immunology (JI).

Faculty

Sudhanshu Agrawal, M.S.

sagrawal@uci.edu

Sudhanshu is a faculty member of the Agrawal Lab who received his Masters at M.S.U. Baroda in Biotechnology in 1988. He was recruited by Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL), where he conducted viral vaccine production in monkey kidney cells and vaccine testing in vitro and in vivo as directed by W.H.O. Sudhanshu went on to work as a scientist the multinational Indian pharmaceutical company Ranbaxy Lab Ltd in New Delhi, where he provided leadership in preclinical testing of NCEs, evaluations for cancer by cell lines based and nude mice assays, and performed assays for other pharmacological NCEs testing.

In Paris, Sudhanshu was recruited by the biopharmaceutical company Immuno-Designed Molecules (IDM) where he provided immuno-monitoring of dendritic cell based vaccine clinical trial in Prostate and Melanoma patients. Before joining the Agrawal Lab at UCI, he was a Senior Research Project Coordinator at Emory Vaccine Center at Emory University where his studies focused on microbial stimuli, modulated dendritic cells function, dendritic cell molecular mechanisms and signaling networks, and induction of different classes of adaptive immune responses.